272 related articles for article (PubMed ID: 19530431)
1. [Pfizer: TLV decision about antilipemic agents is founded on wrong basis].
Brun J; Ohlsson-Onerud A; Sörensen N
Lakartidningen; 2009 Apr 22-28; 106(17):1193-4; discussion 1194. PubMed ID: 19530431
[No Abstract] [Full Text] [Related]
2. [Lean years for patients].
Klose G; Anlauf M
MMW Fortschr Med; 2004 Dec; 146(51-52):16. PubMed ID: 15675237
[No Abstract] [Full Text] [Related]
3. Cost-effectiveness of high-dose atorvastatin compared with regular dose simvastatin.
Lindgren P; Graff J; Olsson AG; Pedersen TJ; Jönsson B;
Eur Heart J; 2007 Jun; 28(12):1448-53. PubMed ID: 17371782
[TBL] [Abstract][Full Text] [Related]
4. Impact of out-of-pocket expenses on discontinuation of statin therapy: a cohort study in Finland.
Helin-Salmivaara A; Korhonen MJ; Alanen T; Huupponen R
J Clin Pharm Ther; 2012 Feb; 37(1):58-64. PubMed ID: 21410736
[TBL] [Abstract][Full Text] [Related]
5. [2008 National Cardiology Guidelines: Prioritization requires consideration to other factors than scientific studies alone].
Eklund K; Grip L; Israelsson B; Levin LA; Lindahl B; Wallentin L
Lakartidningen; 2008 May 7-13; 105(19):1408-9; discussion 1409. PubMed ID: 18574983
[No Abstract] [Full Text] [Related]
6. [Ezetimib plus statin combination. A strong duo].
MMW Fortschr Med; 2002 Nov; 144(48):53. PubMed ID: 12532547
[No Abstract] [Full Text] [Related]
7. [Coronary heart disease patient reaches LDL level of 100 mg/dl with atorvastatin: how do you continue treatment next year?].
Weizel A; Sawicki PT
MMW Fortschr Med; 2004 Dec; 146(51-52):14, 16. PubMed ID: 15675236
[No Abstract] [Full Text] [Related]
8. Managed care trends in statin usage.
Bazalo GR
Manag Care; 2001 Oct; 10(10):48-50, 53-9. PubMed ID: 11688111
[TBL] [Abstract][Full Text] [Related]
9. Lipitor goes generic: business as usual or more big business?
Gill L; Santa J; Peter DL; Keehn J
Ann Intern Med; 2012 Jun; 156(12):892-3, W313. PubMed ID: 22711082
[No Abstract] [Full Text] [Related]
10. What price atorvastatin?
Drug Ther Bull; 2012 Jul; 50(7):73. PubMed ID: 22764068
[No Abstract] [Full Text] [Related]
11. Cost-effectiveness of high-dose atorvastatin compared with usual-dose simvastatin: less than IDEAL?
Kaul P
Eur Heart J; 2007 Jun; 28(12):1405-6. PubMed ID: 17553925
[No Abstract] [Full Text] [Related]
12. [Sequelae of the CARDS Study. LDL of 110 mg/dl still too high?].
Klose G
MMW Fortschr Med; 2004 Jun; 146(26):14. PubMed ID: 15529683
[No Abstract] [Full Text] [Related]
13. [SBU should investigate what is an evidence-based and cost-effective use of statins].
Hjemdahl P; Allhammar A; Heaton C; Hulting J; Kahan T; Malmström R; Martinsson A; Rücker F; Schenck-Gustafsson K; Schwieler J; Törnerud M; Wettermark B
Lakartidningen; 2009 Aug 5-18; 106(32-33):1992-4. PubMed ID: 19764381
[No Abstract] [Full Text] [Related]
14. Generic atorvastatin and health care costs.
Jackevicius CA; Chou MM; Ross JS; Shah ND; Krumholz HM
N Engl J Med; 2012 Jan; 366(3):201-4. PubMed ID: 22149736
[No Abstract] [Full Text] [Related]
15. Generic atorvastatin and health care costs.
Kennally WC
N Engl J Med; 2012 Apr; 366(15):1451; author reply 1451. PubMed ID: 22494136
[No Abstract] [Full Text] [Related]
16. Potent statin goes generic.
Johns Hopkins Med Lett Health After 50; 2006 Dec; 18(10):7. PubMed ID: 17290530
[No Abstract] [Full Text] [Related]
17. Potential neurological value of statins increases.
Bonetta L
Nat Med; 2002 Jun; 8(6):541. PubMed ID: 12042786
[No Abstract] [Full Text] [Related]
18. Lowering copayments: impact of simvastatin patent expiration on patient adherence.
Sedjo RL; Cox ER
Am J Manag Care; 2008 Dec; 14(12):813-8. PubMed ID: 19067498
[TBL] [Abstract][Full Text] [Related]
19. [For coronary disease patients is certain: the lower the LDL the better].
MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797
[No Abstract] [Full Text] [Related]
20. Statins: not just for the young or the faint of heart.
Coull BM; Johnston SC
Neurology; 2009 Feb; 72(8):684-5. PubMed ID: 19237695
[No Abstract] [Full Text] [Related]
[Next] [New Search]